Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

Heart Peptide Hormones: Adjunct and Primary Treatments of Cancer.

Vesely DL.

Anticancer Res. 2016 Nov;36(11):5693-5700. Review.

PMID:
27793890
2.

Subcutaneous pharmacokinetics of the cardiac hormone vessel dilator.

Zhou Q, Whelan G, Zhou SF, Lane ML, Vesely DL.

Clin Exp Pharmacol Physiol. 2014 Aug;41(8):565-70. doi: 10.1111/1440-1681.12266.

PMID:
24889838
3.

Family of peptides synthesized in the human body have anticancer effects.

Vesely DL.

Anticancer Res. 2014 Apr;34(4):1459-66. Review.

PMID:
24692673
4.

Reduction of leptin levels by four cardiac hormones: Implications for hypertension in obesity.

Lane ML, Vesely DL.

Exp Ther Med. 2013 Aug;6(2):611-615. Epub 2013 Jun 21.

5.

Cardiac hormones target nuclear oncogenes c-Fos and c-Jun in carcinoma cells.

Manimala NJ, Frost CD, Lane ML, Higuera M, Beg R, Vesely DL.

Eur J Clin Invest. 2013 Nov;43(11):1156-62. doi: 10.1111/eci.12153. Epub 2013 Sep 2.

PMID:
23992401
6.

Central role of β-catenin in anticancer effects of cardiac hormones.

Skelton WP 4th, Skelton M, Vesely DL.

Anticancer Res. 2013 Jun;33(6):2409-14.

PMID:
23749889
7.

Natriuretic peptides' metabolic targets for treatment of cancer.

Vesely DL.

J Investig Med. 2013 Jun;61(5):816-22. doi: 10.2310/JIM.0b013e318292110a. Review.

PMID:
23612148
8.

Cardiac hormones for the treatment of cancer.

Vesely DL.

Endocr Relat Cancer. 2013 May 30;20(3):R113-25. doi: 10.1530/ERC-13-0054. Print 2013 Jun. Review.

9.

Inhibition of AKT in human pancreatic, renal and colorectal cancer cells by four cardiac hormones.

Skelton WP 4th, Skelton M, Vesely DL.

Anticancer Res. 2013 Mar;33(3):785-90.

PMID:
23482745
10.

Pituitary tumor with gigantism, acromegaly and preclinical Cushing's disease diagnosed from the 10th row.

Tourtelot JB, Vesely DL.

Am J Med Sci. 2013 Aug;346(2):169-71. doi: 10.1097/MAJ.0b013e3182831919.

PMID:
23462247
11.

Cardiac hormones are potent inhibitors of secreted frizzled-related protein-3 in human cancer cells.

Skelton WP 4th, Skelton M, Vesely DL.

Exp Ther Med. 2013 Feb;5(2):475-478. Epub 2012 Nov 12.

12.

Potent selective inhibition of STAT 3 versus STAT 1 by cardiac hormones.

Lane ML, Frost CD, Nguyen JP, Skelton WP 4th, Skelton M, Vesely DL.

Mol Cell Biochem. 2012 Dec;371(1-2):209-15. doi: 10.1007/s11010-012-1437-1. Epub 2012 Sep 11.

PMID:
22965761
13.

New anticancer agents: hormones made within the heart.

Vesely DL.

Anticancer Res. 2012 Jul;32(7):2515-21. Review.

PMID:
22753708
14.

Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor.

Nguyen JP, Frost CD, Lane ML, Skelton Iv WP, Skelton M, Vesely DL.

Eur J Clin Invest. 2012 Oct;42(10):1061-7. doi: 10.1111/j.1365-2362.2012.02695.x. Epub 2012 Jun 15.

PMID:
22703300
15.

Cardiac hormones are c-Jun-N-terminal kinase 2-inhibiting peptides.

Lane ML, Santana O, Frost CD, Nguyen J, Guerrero J, Skelton WP 4th, Skelton M, Vesely DL.

Anticancer Res. 2012 Mar;32(3):721-5.

PMID:
22399583
16.

Four cardiac hormones cause death of human cancer cells but not of healthy cells.

Skelton WP 4th, Pi GE, Vesely DL.

Anticancer Res. 2011 Feb;31(2):395-402.

PMID:
21378317
17.

Cardiac Hormones Target the Ras-MEK 1/2-ERK 1/2 Kinase Cancer Signaling Pathways.

Vesely DL.

Cancers (Basel). 2011 Mar 8;3(1):1182-94. doi: 10.3390/cancers3011182.

18.

Vessel dilator and C-type natriuretic peptide enhance the proliferation of human osteoblasts.

Lenz A, Bennett M, Skelton WP 4th, Vesely DL.

Pediatr Res. 2010 Nov;68(5):405-8. doi: 10.1203/PDR.0b013e3181ef7636.

PMID:
20613683
19.

Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cells.

Skelton WP 4th, Pi G, Lenz A, Sun Y, Vesely DL.

Eur J Clin Invest. 2010 Aug;40(8):706-12. doi: 10.1111/j.1365-2362.2010.02309.x. Epub 2010 Jun 7.

PMID:
20546014
20.

Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.

Lenz A, Sun Y, Eichelbaum EJ, Skelton WP 4th, Pi G, Vesely DL.

Eur J Clin Invest. 2010 Mar;40(3):242-9. doi: 10.1111/j.1365-2362.2010.02262.x.

PMID:
20415699
21.

Twice-weekly intravenous treatment of pancreatic cancer with atrial natriuretic peptide and vessel dilator.

Lenz A, Sun Y, Eichelbaum EJ, Skelton WP 4th, Pi G, Vesely DL.

In Vivo. 2010 Mar-Apr;24(2):125-9.

PMID:
20363982
22.

Epidermal growth factor's activation of Ras is inhibited by four cardiac hormones.

Sun Y, Eichelbaum EJ, Lenz A, Wang H, Vesely DL.

Eur J Clin Invest. 2010 May;40(5):408-13. doi: 10.1111/j.1365-2362.2010.02283.x. Epub 2010 Mar 25.

PMID:
20353436
23.

Metabolic targets of cardiac hormones' therapeutic anti-cancer effects.

Vesely DL.

Curr Pharm Des. 2010;16(9):1159-66. Review.

PMID:
20030620
24.

Atrial natriuretic peptide and long-acting natriuretic peptide inhibit ras in human prostate cancer cells.

Sun Y, Eichelbaum EJ, Lenz A, Skelton WP 4th, Wang H, Vesely DL.

Anticancer Res. 2009 Jun;29(6):1889-93.

25.

Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells.

Sun Y, Eichelbaum EJ, Skelton WP 4th, Lenz A, Wang H, Vesely DL.

Anticancer Res. 2009 Apr;29(4):971-5.

26.

Langerhans cell deficiency impairs Ixodes scapularis suppression of Th1 responses in mice.

Vesely DL, Fish D, Shlomchik MJ, Kaplan DH, Bockenstedt LK.

Infect Immun. 2009 May;77(5):1881-7. doi: 10.1128/IAI.00030-09. Epub 2009 Mar 9.

27.

Cardiac natriuretic peptides gene expression and secretion in inflammation.

de Bold AJ.

J Investig Med. 2009 Jan;57(1):29-32. doi: 10.2310/JIM.0b013e3181948b37. Review. Erratum in: J Investig Med. 2009 Aug;57(6):736. Vesely, David L [removed].

PMID:
19158604
28.

Cardiac and renal hormones: anticancer effects in vitro and in vivo.

Vesely DL.

J Investig Med. 2009 Jan;57(1):22-8. doi: 10.2310/JIM.0b013e3181948b25. Review.

PMID:
19092678
29.

Cardiac hormones activate ERK 1/2 kinases in human fibroblasts.

Sun Y, Eichelbaum EJ, Wang H, Vesely DL.

Horm Metab Res. 2009 Mar;41(3):197-201. doi: 10.1055/s-0028-1087206. Epub 2008 Oct 14.

PMID:
18855305
30.

Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice.

Eichelbaum EJ, Sun Y, Alli AA, Gower WR Jr, Vesely DL.

Eur J Clin Invest. 2008 Aug;38(8):562-70. doi: 10.1111/j.1365-2362.2008.01978.x.

PMID:
18717826
31.
32.

Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice.

Vesely DL, Vesely BA, Eichelbaum EJ, Sun Y, Alli AA, Gower WR Jr.

In Vivo. 2007 Nov-Dec;21(6):973-8.

33.

Four cardiac hormones cause cell death of melanoma cells and inhibit their DNA synthesis.

Vesely BA, Eichelbaum EJ, Alli AA, Sun Y, Gower WR Jr, Vesely DL.

Am J Med Sci. 2007 Nov;334(5):342-9.

PMID:
18004088
34.

Urodilatin: a better natriuretic peptide?

Vesely DL.

Curr Heart Fail Rep. 2007 Sep;4(3):147-52. Review.

PMID:
17883990
35.

Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.

Sun Y, Eichelbaum EJ, Wang H, Vesely DL.

Anticancer Res. 2007 May-Jun;27(3B):1387-92.

36.

Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones.

Vesely DL, Eichelbaum EJ, Sun Y, Alli AA, Vesely BA, Luther SL, Gower WR Jr.

In Vivo. 2007 May-Jun;21(3):445-51.

37.

Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours.

Eichelbaum EJ, Vesely BA, Alli AA, Sun Y, Gower WR Jr, Vesely DL.

Endocrine. 2006 Dec;30(3):325-32.

PMID:
17526945
38.

Four cardiac hormones eliminate 4-fold more human glioblastoma cells than the green mamba snake peptide.

Vesely BA, Eichelbaum EJ, Alli AA, Sun Y, Gower WR Jr, Vesely DL.

Cancer Lett. 2007 Aug 28;254(1):94-101. Epub 2007 Mar 30.

PMID:
17399891
39.

Discovery of new cardiovascular hormones for the treatment of congestive heart failure.

Vesely DL.

Cardiovasc Hematol Disord Drug Targets. 2007 Mar;7(1):47-62. Review.

PMID:
17346128
40.

Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells.

Sun Y, Eichelbaum EJ, Wang H, Vesely DL.

Anticancer Res. 2006 Nov-Dec;26(6B):4143-8.

41.

Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-6 protection against p53-induced apoptosis in M1 myeloid leukemic cells.

Vesely DL, Hoffman B, Liebermann DA.

Oncogene. 2007 May 10;26(21):3041-50. Epub 2006 Nov 13.

PMID:
17099722
42.

Vessel dilator and kaliuretic peptide inhibit ERK 1/2 activation in human prostate cancer cells.

Sun Y, Eichelbaum EJ, Wang H, Vesely DL.

Anticancer Res. 2006 Sep-Oct;26(5A):3217-22.

43.

Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers.

Vesely BA, Eichelbaum EJ, Alli AA, Sun Y, Gower WR Jr, Vesely DL.

Eur J Clin Invest. 2006 Nov;36(11):810-9.

PMID:
17032349
44.

Circadian distribution of hematology variables in subjects with multiple sclerosis.

Kanabrocki EL, Vesely DL, Hermida RC, Ayala DE, Ryan MD, Burden J, Shah F, Friedman NC, Eladasari B, Nemchausky BA, Dawson S, McCormick JB, Alessandrini SM, Hooper DC.

Clin Ter. 2006 May-Jun;157(3):241-7.

PMID:
16900851
45.

Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via cyclic GMP.

Gower WR, Vesely BA, Alli AA, Vesely DL.

Int J Gastrointest Cancer. 2005;36(2):77-87.

PMID:
16648657
46.

Cardiac natriuretic peptides: hormones with anticancer effects that localize to nucleus, cytoplasm, endothelium, and fibroblasts of human cancers.

Saba SR, Vesely DL.

Histol Histopathol. 2006 Jul;21(7):775-83. doi: 10.14670/HH-21.775. Review.

PMID:
16598676
47.

Primary malignant tumors of the heart: four cardiovascular hormones decrease the number and DNA synthesis of human angiosarcoma cells.

Vesely BA, Alli A, Song S, Sanchez-Ramos J, Fitz SR, Gower WR Jr, Vesely DL.

Cardiology. 2006;105(4):226-33. Epub 2006 Mar 3.

PMID:
16534199
48.
49.

Atrial natriuretic peptides: anticancer agents.

Vesely DL.

J Investig Med. 2005 Nov;53(7):360-5. doi: 10.2310/6650.2005.53708. Review.

PMID:
16297362
50.

Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.

Vesely BA, Alli AA, Song SJ, Gower WR Jr, Sanchez-Ramos J, Vesely DL.

Eur J Clin Invest. 2005 Nov;35(11):700-10.

PMID:
16269020

Supplemental Content

Loading ...
Support Center